FactorPad
Build a Better Process

Stock Risk Measures for Theravance Biopharma Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 71 for TBPH below.

/ factorpad.com / stocks / f48xcn.html


An ad-free and cookie-free webpage by FactorPad


TBPH Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Theravance Biopharma Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how TBPH stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Pharmaceuticals: Other industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f48xcn.html


TBPH stock risk
THERAVANCE BIOPHARMA INC stock beta
TBPH risk report
TBPH f48xcn
TBPH risk analysis
TBPH volatility
THERAVANCE BIOPHARMA INC credit risk
TBPH liquidity risk
TBPH leverage
TBPH valuation
TBPH systematic risk
TBPH specific risk
THERAVANCE BIOPHARMA INC volatility
TBPH analysis
TBPH financial ratio

This is a new resource, spread the word, tell a friend